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, and H 2 O transport in the kidney (8, 9) . Activation of the CaR, expressed on the basolateral membranes of the TAL, inhibits salt transport in a furosemide-like manner (7, 27) . The CaR is also expressed by primary cultures of mTAL cells, mediating increases of tumor necrosis factor (TNF) production and cyclooxygenase-2 (COX-2) expression as well as prostaglandin E 2 (PGE 2 ) synthesis thereby contributing to a mechanism that regulates NaCl reabsorption in this nephron segment (55) (56) (57) . The lumen-positive transepithelial voltage in the TAL facilitates paracellular divalent cation reabsorption; CaR senses the rise in extracellular Ca 2ϩ and transduces a series of intracellular signals that culminate in Ca 2ϩ excretion. Chronic hypercalcemia and the resulting hypercalciuria predispose renal manifestations of reduced NaCl reabsorption, urinary concentrating defects, phosphaturia, and polyuria (48) . Moreover, selected mutations of the CaR have been observed in Bartter syndrome (hyperprostaglandin E syndrome) associated with reduced salt absorption by the TAL and hypokalemia (28) .
CaR regulates TAL function by 1) a "short-term" inhibitory effect of 20-HETE on apical K ϩ channels, inhibition of cAMP, and an increase in phosphodiesterase activity and 2) a "long-term" mechanism involving TNF/COX-2/PGE 2 (29, 57, 59) . These mechanisms are dependent on activation of G proteins including G␣ q and G␣ i2 linked to signaling pathways that act in a cell type-dependent manner (63) . Cross talk between G q -and G icoupled mechanisms appears to influence the net effect of CaR activation. For instance, we recently showed that the CaR in the mTAL is coupled to G q and G i signaling cascades culminating in TNF production in response to nuclear factor of activated T cells (NFAT) (1, 2) .
The finding that the CaR activates NFAT in mTAL cells suggests a link between NFAT-mediated TNF production and function in this segment of the nephron. Activation of the CaR increases [Ca 2ϩ ] i , which forms a complex with calmodulin to activate calcineurin (CaN) that serves as a component in a CaN/ NFAT mechanism regulating TNF and PGE 2 production in the mTAL. In addition, CaR activation increased COX-2-derived PGE 2 synthesis via a protein kinase C (PKC)-dependent mechanism; direct activation with phorbol myristate acetate also increased COX-2 expression and PGE 2 production in mTAL cells (20, 57) . Thus, multiple signaling pathways regulate CaR-dependent TNF production in the mTAL via a mechanism involving both G q -and G i -coupled pathways (1, 2, 57) . In the present study, we determined whether the signaling mechanisms that contribute to CaR-mediated TNF production are linked to COX-2-derived PGE 2 and its ability to regulate ouabain-sensitive O 2 consumption in the mTAL, an in vitro correlate of Na ϩ movement from tubular fluid to the interstitial space. We postulate that blockade of CaR signaling pathways in the mTAL, which participate in both TNF production and COX-2-derived PGE 2 synthesis, would negate the ability of the CaR to regulate mTAL transport function as evidenced by reversing the inhibitory effects of CaR activation on ouabain-sensitive O 2 consumption.
MATERIALS AND METHODS
Animals. Male Sprague-Dawley rats (Charles River Lab, Wilmington, MA) weighing 100 -110 g were maintained on standard rat chow (Ralston-Purina, Chicago, IL) and given tap water ad libitum.
Reagents. Tissue culture media were obtained from Life Technologies (Grand Island, NY). Reagent-grade chemicals and collagenase (type 1A) were from Sigma (St. Louis, MO). Polyvinylidene difluoride (PVDF) membranes were obtained from Amersham (Arlington Heights, IL). The phosphoinositol phospholipase C (PI-PLC) inhibitor, U73122, and inactive analog, U73343, as well as pertussis toxin (PTX), GF 109203X, and NS-398 were purchased from BIOMOL; cyclosporin A (CsA), VIVIT, and the PTX B-Oligomer were purchased from Calbiochem. Preliminary experiments were performed to establish the optimal conditions for each inhibitor with respect to concentration and time.
Isolation of mTAL cells. The isolation and characterization of mTAL cells (ϳ95% purity) were performed as previously described (12, 19) . In brief, male Sprague-Dawley rats were anesthetized with an intraperitoneal injection of pentobarbital sodium (0.65 mg/100 g body wt). The kidneys were perfused with sterile 0.9% saline, via retrograde perfusion of the aorta, and cut along the corticopapillary axis. The inner stripe of the outer medulla was excised, minced with a sterile blade, and incubated for 10 min at 37°C in a 0.1% collagenase solution gassed with 95% oxygen. The suspension was sedimented on ice, mixed with HBSS containing 2% BSA, and the supernatant containing the crude suspension of tubules was collected. The collagenase digestion was repeated three times with the remaining undigested tissue. The combined supernatants were centrifuged for 10 min, resuspended in HBSS, and filtered through a 52-m nylon mesh membrane (Fisher Scientific, Springfield, NJ). The filtrated solution was discarded, and the tubules retained on the mesh were resuspended in HBSS. Then, the solution was centrifuged at 500 rpm for 10 min, supernatant was aspirated, and the cells were cultured in renal epithelial cell basal medium (REBM, Cambrex), containing renal epithelial cell growth medium (REGM, Cambrex) consisting of rhEGF, insulin, hydrocortisone, GA-1000 (gentamycin sulfate and amphotericin B), 0.5% FBS, epinephrine, triiodothyronine, and transferrin. After 3-4 days, monolayers of cells were 80 -90% confluent. The cells were quiesced for 24 h in RPMI containing 0.42 mM CaCl2 and 0.5% FBS, L-glutamine (2 mM), 100 U/ml streptomycin-penicillin (GIBCO), MEM nonessential amino acids (GIBCO), MEM sodium pyruvate, and ␤-mercaptoethanol before their use. In all experiments, "control conditions" (i.e., no addition of CaCl 2) reflects that cells were incubated in media containing 0. 42 (62) . Western blot analysis. Cells were pretreated with U73122 (500 nM), the synthetic peptide VIVIT (20 M), CsA (0.55 ng/ml), PTX (100 ng/ml), or GF 109203X (20 nM) for 15 min-1 h before incubation of cells with or without 1.2 mM Ca 2ϩ for 6 h. The quiescence media was removed and cells were washed three times with cold PBS, scraped, and collected with 200 l/well of lysis buffer (100 mM Tris ⅐ HCl, pH 7.6, 5 mM EDTA, 1% SDS, and 1 mM PMSF added fresh). Protein concentrations were determined using a detergentcompatible Bio-Rad protein assay kit. Cell lysates were normalized according to protein concentration with the same lysis buffer; and subsequently mixed with an equal volume of 5ϫ SDS-PAGE protein loading buffer. Samples were boiled in water for 5 min, before protein separation on a 10% SDS-PAGE gel and transferred to PVDF membranes. Subsequently, the PVDF membranes were washed two times in PBS. Membranes were blocked in 5% blotting grade blocker nonfat dry milk (Bio-Rad) with 0.1% Tween 20 (Fisher Scientific). Then, membranes were incubated with rabbit anti-mouse COX-2 polyclonal antibody (1:1,000; Cayman), diluted in 1% nonfat dry milk with 0.1% Tween 20, at room temperature. Membranes were washed three times with 1ϫ TBS-Tween or PBS-Tween and then incubated in goat anti-rabbit IgG-horseradish peroxidase (1:5,000; Santa Cruz Biotechnology) for 30 min. Finally, membranes were washed three times and developed with the Amersham ECL Western blotting detection reagents and exposed on Kodak Biomax Light Film (Fisher).
Measurement of PGE2. Primary cultured rat mTAL cells were quiesced overnight and then incubated with or without 1.2 mM CaCl 2 for 6 h at 37°C/5% CO2. PGE2 levels in cell-free supernatants were determined by ELISA (Cayman), according to the protocol provided by the manufacturer and as previously reported (57) .
Transient transfection. mTAL cells were cultured to 70 -80% confluence and transfected as described (55) . In brief, the medium was removed and cells were placed in 1 ml of serum-free OPTI-MEM medium containing 7 g/well of either plasmid DNA containing a dominant negative R796W CaR constructor empty plasmid vector (pcDNA3.1) and 10 l lipofectamine reagent (Life Technologies) for 4 h at 37°C/5% CO2 (42) . After the transfection period, 1 ml of REGM containing 0.5% FBS was added and the cells were incubated overnight at 37°C/5% CO2. The medium was then removed, and cells were cultured for an additional 12 h in REGM containing 0.5% FBS. The cells were quiesced overnight in RPMI medium containing 0.5% FBS and then treated with the appropriate reagents for the indicated times. Transfection efficiency was evaluated as described (1) .
Measurement of oxygen consumption. Oxygen consumption was measured as described (17) . In brief, quiescence medium (RPMI 1640 containing 0.5% FBS) was aspirated and replaced with 1 ml/well dispase (BD Biosciences) and incubated for 45 min at 37°C/5% CO2. Cells were then collected into a plastic centrifuge tube, centrifuged at 500 rpm for 10 min, and washed three times to remove remaining dispase. The final cell density was adjusted to contain 25,000 cells in 100 l and oxygen consumption was determined in 96-well round bottom plates coated with a proprietary biosensor, which fluoresces when oxygen is depleted (BD Biosciences). The plates were read on a Bio-Tek FLx 800 fluorescence microplate reader, set to read the bottom of the plate with excitation/emission wavelengths at 485/620 nm; octuplet fluorescence readings were converted to oxygen consumption rates using the KC4 (Kineticalc) program according to the manufacturer's protocol. Ouabain-sensitive O 2 consumption is an index of Na ϩ -K ϩ -ATPase activity in mTAL cells and was determined by taking the difference between cells incubated without (total oxygen consumption) or with ouabain (1 mM). All inhibitors used in the study also were tested in the absence or presence of ouabain.
The assay is based on the hydrolysis of ATP in the presence and absence of ouabain (15) . Total phosphate released was determined by a microplate assay using the Biomol green reagent. The reaction mixture consists of (in mM) 37.5 imidazole, 75 NaCl, 5 KCl, 1.0 EGTA, 5 MgCl2, 6 NaN3, and 75 Tris ⅐ HCl (solution A) and 4 mM ATP. To assess ouabain-insensitive phosphate release, solution A was modified to contain 1 mM ouabain and 150 mM Tris, and no NaCl or KCl (solution B). Confluent cultures in six-well plates were washed two times with scraping buffer (300 mM mannitol, 10 mM Tris, 10 mM HEPES, pH 7.4) and then harvested and centrifuged at 5,000 rpm for 5 min. The pellet was resuspended in a 1:10 dilution of solution B and subjected to three cycles of freezethaw; protein concentration was determined. Aliquots of protein were preincubated for 10 min at 37°C in solution A or B. The reaction was initiated by addition of 4 mM ATP and continued for 5 min at 37°C. The reaction was stopped by rapidly transferring the tubes to an ice-cold water bath, followed by the addition of 50 l of 50% ice-cold TCA. After 10 min, the reaction mixture was centrifuged at 10,000 rpm and the supernatant was diluted 1:20 for determination of inorganic phosphate. An aliquot (50 l) of the reaction mixture was incubated in a 96-well plate with 100 l of Biomol green reagent for 20 -30 min at room temperature; absorbance at 620 nm was determined. A standard curve was constructed using a potassium phosphate solution supplied by the manufacturer. The reactions were carried out under conditions that enabled measurements to fall within the linear part of the standard curve. Biomol green is a proprietary formulation of Malachite green made by Biomol for phosphate determinations.
Statistical analysis. Data were compared by a one-way ANOVA followed by the Newman-Keuls test when multiple comparisons were made. Data are presented as means Ϯ SE; P Յ 0.05 was considered statistically significant. 2 synthesis in mTAL cells. Inhibition of G q with U73122, a PI-PLC inhibitor, and G i with PTX revealed the extent to which these pathways contribute to CaR-mediated COX-2 expression in mTAL cells. Cells were quiesced overnight and then preincubated for 15 min, with or without U73122 (500 nM), before addition of Ca 2ϩ (1.2 mM) for 6 h. Pretreatment with U73122 abolished Ca 2ϩ -mediated increases in COX-2 protein expression indicating that PI-PLC contributes to COX-2 expression in mTAL cells (Fig. 1A) . Similarly, cells were preincubated for 1 h, with or without PTX (100 ng/ml) or the PTX B-oligomer (enzymatically inactive subunit; 100 ng/ml), before Ca 2ϩ stimulation. PTX abolished Ca 2ϩ -mediated increases in COX-2 protein expression (Fig. 1B) . In contrast, COX-2 expression was not altered in cells challenged with Ca 2ϩ following preincubation with PTX B-oligomer suggesting that the enzymatically active A-protomer in PTX, which is involved in ADP ribosylation of the cysteine moiety on the alpha subunit of G i , was responsible for the inhibitory effect of PTX (Fig. 1B) .
RESULTS

CaR-mediated activation of G q and G i increases COX-2 expression and PGE
We reported that CaR-mediated PGE 2 synthesis in mTAL cells is COX-2 dependent (55). Since G q and G i play major roles in the regulation of COX-2 expression in these cells, we tested the role of the two G proteins on PGE 2 synthesis, following CaR activation. Addition of Ca 2ϩ increased PGE 2 synthesis that was inhibited by pretreatment with the U73122, but not the inactive analog U73343 (Fig. 1C) . Neither basal PGE 2 synthesis nor cell viability was altered by these compounds. Similarly, pretreatment for 1 h with PTX, but not the inactive B-oligomer, inhibited CaR-mediated PGE 2 synthesis, but had no effect on basal PGE 2 synthesis (Fig. 1D) . Collectively, these data suggest that G q -and G i -coupled signaling initiated by CaR activation is required for COX-2-derived PGE 2 production by mTAL cells.
CaR-mediated COX-2 expression and PGE 2 synthesis are CaN and NFAT dependent. Previous work demonstrated that COX-2 expression in the outer medulla of the kidney is CaN dependent; however, the cell type in which this occurred was not identified (30) . We determined whether CaN/NFAT signaling mediates CaR-mediated COX-2 expression in mTAL cells. Application of CsA, which forms a complex with cyclophilin and subsequently inhibits CaN phosphatase activity by Fig. 1 . Effects of Gq and Gi inhibition on calcium-sensing receptor (CaR)-stimulated increases in cyclooxygenase (COX)-2 expression and prostaglandin E2 (PGE2) production. A: pretreatment with U73122 (500 nM) for 15 min abolished induction of COX-2 protein expression; n ϭ 4 -10. B: pretreatment with pertussis toxin (PTX; 100 ng/ml) for 1 h abolished Ca 2ϩ -mediated increases in COX-2 protein expression; the enzymatically inactive PTX B-oligomer subunit (100 ng/ml) had no effect; n ϭ 3-10. C and D: stimulation with 1.2 mM Ca 2ϩ for 6 h increased PGE2 synthesis; pretreatment with U73122 (500 nM) or PTX (100 ng/ml) inhibited CaR-activated increases in PGE2 production but did not alter basal production; n ϭ 7. directly binding the CaN-A subunit of CaN (39), was used to determine whether CaN is required for CaR-mediated increases in COX-2 expression and PGE 2 synthesis. Indeed, pretreatment with CsA (0.55 ng/ml) abolished Ca 2ϩ -mediated increases in COX-2 expression and PGE 2 synthesis (Fig. 2, A and B) . A role for CaN in producing COX-2 expression and PGE 2 synthesis in mTAL cells was also supported by selective blockade of the CaN binding site for NFAT with a high-affinity peptide, VIVIT (20 M), which prevented CaR-mediated COX-2 expression and PGE 2 synthesis (Fig. 2, A and B) . These findings indicate that a CaN/NFAT interaction regulates COX-2 expression and PGE 2 synthesis in mTAL cells.
Activation of the CaR inhibits ouabain-sensitive O 2 consumption. As a large component of total O 2 consumption in mTAL cells is committed to the transport of Na ϩ , determination of ouabain-sensitive O 2 consumption was used to screen for alterations in ion transport function in response to CaR activation. This method is a useful index of Na ϩ transport in renal epithelial cells. Basically, increased O 2 consumption by the mTAL indicates increased transport by this segment, whereas a decline in O 2 consumption indicates decreased transport that can be reversed by inhibiting CaR signaling pathways (13, 54) . We previously showed using a Clark-type electrode that ouabain (1 mM), an inhibitor of the basolateral Na ϩ -K ϩ -ATPase, and bumetanide, a selective inhibitor of the apical Na ϩ -K ϩ -2Cl Ϫ cotransporter (NKCC2), inhibited ouabain-sensitive O 2 consumption by ϳ40 -60% in mTAL cells (19) ; similar results were obtained using the present detection method. CaR-mediated inhibition of ouabain-sensitive O 2 consumption in mTAL cells was prevented when cells were transiently transfected with a dominant negative (R796W) CaR construct, whereas transfection with an empty vector (pcDNA3.1) was without effect on the inhibitory action of Ca 2ϩ on O 2 consumption (Fig. 3) . Therefore, Ca 2ϩ -mediated decreases in ouabain-sensitive O 2 consumption appear to be a specific function of CaR activation.
An inhibitory effect on ouabain-sensitive O 2 consumption in mTAL cells reflects either a direct effect on Na ϩ -K ϩ -ATPase activity or secondary effect on Na ϩ pump activity due to inhibition at sites that regulate Na ϩ entry. Accordingly, Na ϩ -K ϩ -ATPase activity was measured to determine whether CaR activation in mTAL cells affects Na ϩ influx or efflux. Cells were exposed to Ca 2ϩ for 6 h, protein concentration was determined, and inorganic phosphate was measured in samples optimized for enzyme kinetics using Biomol green (Biomol). Na ϩ -K ϩ -ATPase activity (ouabain-sensitive fraction) was determined under V max conditions and calculated as the difference between total ATPase (assayed in the absence of ouabain) and ouabain-resistant ATPase (assayed in the presence of 1 mM ouabain). CaR activation did not affect Na 4 cells], and slightly greater inhibition was apparent when amiloride was added together with bumetanide (ϳ45-50%). The 40% inhibition in O 2 consumption in response to bumetanide (100 M) is similar to inhibition of cotransporter activity determined in mTAL cells using 86 Rb uptake (19, 35) . CaR activation did not inhibit O 2 consumption in the presence of bumetanide/amiloride. These findings support the interpretation that CaR activation inhibits NKCC2 activity and additionally that the decrease in ouabain-sensitive O 2 consumption occurs subsequent to inhibition of Na ϩ influx. CaR activation decreases O 2 consumption via COX-2. Secondary inhibition of Na ϩ -K ϩ -ATPase activity in the mTAL, subsequent to inhibition of apical K ϩ channel and NKCC2 activity by PGE 2 , is the basis for decreased ouabain-sensitive O 2 consumption (32, 37). As CaR activation increases COX-2 expression and PGE 2 synthesis in mTAL cells, the effects of COX-2 inhibition on CaR-mediated ouabain-sensitive O 2 consumption were determined. Activation of the CaR inhibited O 2 consumption by ϳ70% (Fig. 4) . Pretreatment for 30 min with the selective COX-2 inhibitor NS-398 (1 M) partially reversed CaR-mediated decreases in O 2 consumption, but did not alter basal level O 2 consumption (Fig. 4) . Thus, the effects of CaR activation on mTAL O 2 consumption appear to involve a COX-2-dependent component. These data indicate that CaR activation and COX-2 expression contribute to a mechanism that affects ion transport in mTAL cells.
Identification of signaling pathways that regulate ouabainsensitive O 2 consumption in mTAL cells.
We hypothesized that inhibition of each of the pathways involved in CaR-mediated COX-2-derived PGE 2 synthesis should also prevent CaR-mediated decreases in ouabain-sensitive O 2 consumption. Inhibition of signaling via G q , by pretreatment for 15 min with U73122, and G i , by pretreatment for 1 h with PTX, abolished Ca 2ϩ -mediated decreases in O 2 consumption (Fig. 5, A and B) . In contrast, neither inhibitor affected basal level O 2 consumption or cell viability.
We showed that CaR activation increases PKC activity in mTAL cells, which contributes to COX-2-derived PGE 2 synthesis (57) . Inhibition of PKC activity by pretreatment with GF 109203X (20 nM) for 15 min before addition of Ca 2ϩ partially reversed CaR-mediated decreases in O 2 consumption, suggesting that PKC contributes to the regulation of mTAL transport function (Fig. 6) . Moreover, an increase in PKC activity was also shown to be essential to G q -and G i -mediated stimulation of CaN activity (1, 2) . Accordingly, as we showed that the CaR utilizes a CaN-/NFAT-dependent mechanism to induce COX-2-derived PGE 2 synthesis, we assessed mTAL O 2 consumption in the absence and presence of CsA and VIVIT. CsA (0.55 ng/ml) reversed CaR-mediated decreases in O 2 consumption by ϳ50%, while the selective CaN/NFAT peptide inhibitor, VIVIT, reversed the Ca 2ϩ -mediated decrease in ouabain-sensitive O 2 consumption (Fig. 7) . Thus, a CaN-NFAT interaction also presumably regulates CaR-mediated ion transport function in the mTAL.
DISCUSSION
We demonstrated that G q -and G i -coupled CaR signaling pathways mediated COX-2-derived PGE 2 synthesis and that each pathway regulates mTAL ion transport. We found that inhibition of CaR signaling via PI-PLC, PKC, CaN/NFAT, or Fig. 3 . Overexpression of a dominant negative CaR mutant (R796W) reverses calcium-mediated decreases in O2 consumption. mTAL cells were transiently transfected with either empty vector (pcDNA3.1) or R796W (7 g/well). After transfection, the cells were quiesced overnight and then challenged with Ca (1.2 mM) for 6 h in the presence or absence of ouabain (1 mM). The Ca 2ϩ -mediated decrease in ouabain-sensitive O2 consumption was prevented in cells transfected with the inactive CaR mutant, R796W, but not pcDNA3.1 empty vector; n ϭ 3. Fig. 4 . NS-398, a selective COX-2 inhibitor, reverses CaR-mediated decreases in O2 consumption. mTAL cells were preincubated in the absence or presence of NS-398 (1 M) for 20 min and then challenged with 1.2 mM Ca 2ϩ for 6 h. Ouabain-sensitive O2 consumption was determined as indicated in MATERIALS AND METHODS; n ϭ 3. G i markedly decreased COX-2 protein expression, PGE 2 production, and ouabain-sensitive O 2 consumption (1, 55-57). Moreover, G q -and G i -coupled CaR signaling likely converge at a proximal step in the cascade that may include an interaction at either the receptor or G protein level. Thus, inhibition of either G q or G i abolished all Ca 2ϩ -stimulated increases in all the aforementioned signaling mediators and reversed PGE 2 -mediated inhibition of mTAL transport. These data suggest that cross-talk between CaR-mediated signaling pathways culminates in a mechanism that contributes to mTAL-related sodium and chloride movement.
The robust Ca 2ϩ -activated decrease in O 2 consumption that was reversed by inhibition of signal transduction suggests that the CaR may be one of the primary regulators of mTAL function. There are many studies addressing the role of Na ϩ and K ϩ in blood pressure (BP) regulation. However, Ca 2ϩ also occupies an important position as it is both a key intracellular second messenger and important extracellular "first" messenger (9) . The signaling pathways addressed in the present study were associated with all-or-none responses with respect to both COX-2-derived PGE 2 synthesis and ouabain-sensitive O 2 consumption in response to CaR activation. We recently demonstrated that inhibition of these same pathways also blocked CaR-mediated TNF production in mTAL cells, which is regulated by a CaN-/NFAT-dependent mechanism (2). Moreover, initiation of G q after CaR activation in the mTAL is associated with inhibition of apical K ϩ channels via a 20-HETE-dependent effect (58, 59 ). The role of G i and a PTX-sensitive mechanism that regulates TAL function may have a timesensitive and/or nephron-specific component as the ability of extracellular Ca 2ϩ to inhibit vasopressin-stimulated cAMP production was PTX insensitive in the rat cTAL challenged with Ca 2ϩ for 4 min (16), while in the present study COX-2-dependent PGE 2 synthesis and inhibition of O 2 consumption after CaR activation for 6 h were PTX sensitive. These findings are reminiscent of other short-and long-term regulatory mechanisms in the TAL; namely, a prevalent CYP450 short-term (min) effect, whereas COX-2 dependency (h) was shown to predominate in long-term regulation of transport function in the mTAL (21) . In any event, activation of CaR in the TAL is associated with several mechanisms that contribute to its loop diuretic-like effects. This concept is supported by the existence of selected activating mutations of the CaR in which patients with Bartter syndrome present with salt and Ca 2ϩ wasting due to reduced ion transport in the TAL affected by PGE 2 and explains the beneficial effects of nonsteroidal anti-inflammatory drugs in reducing the natriuresis, hypercalciuria, and polyuria of Bartter syndrome (28, 41) .
The inhibitory effects of CaR activation on ouabain-sensitive O 2 consumption via COX-2, in the absence of a direct effect on Na ϩ -K ϩ -ATPase activity in mTAL cells, suggest that CaR activation inhibits Na ϩ entry in these cells. The transport of NaCl across the apical membrane of the TAL occurs mainly via the bumetanide-sensitive NKCC2 (22, 31) . The reabsorption of NaCl is then completed, as Na ϩ exits the cell via the basolateral Na ϩ -K ϩ -ATPase, while Cl Ϫ diffuses along its electrochemical gradient through basolateral KCl cotransporters or Cl Ϫ channels. However, the data do not rule out the possibility that CaR activation affects mTAL transport by more than one mechanism as the apical K ϩ channel is a major contributor to K ϩ recycling, which is essential for maintenance of NKCC2 activity (23, 26) . As indicated, TAL function is subject to both short-and long-term regulatory mechanisms. For instance, long-term increases in circulating vasopressin levels increase expression of the NKCC2 and transepithelial chloride transport in the TAL (5, 33). Short-term regulation of NKCC2 has also been observed and involves effects on both activity and trafficking (18, 24, 43, 44, 47) . CYP450-and COX-derived metabolites of arachidonic acid (AA) inhibit ion transport in the mTAL by several different mechanisms including interactions with apical K ϩ channels and NKCC2 (32, 37, 38, 52, 53) . Thus, it is important to understand how molecules that act in the TAL affect AA metabolism since regulation of ion transport in this segment may occur in response to signals induced by receptor activation (20, 21, 58, 60) . Indeed, PGE 2 inhibits apical K ϩ channel, as well as NKCC2 activity, in murine mTAL cells, the latter by a mechanism that is not secondary to inhibition of Na ϩ -K ϩ -ATPase (32, 37). The epidemiological literature indicates an inverse relationship between Ca 2ϩ intake and BP; individuals with the lowest Ca 2ϩ intake (Ͻ700 mg/day) had the highest BP. Increased Ca 2ϩ intake decreases BP in several experimental models of hypertension; however, clinical studies based on patients with higher baseline Ca 2ϩ levels may fail to detect an effect of Ca 2ϩ supplementation on BP because of a ceiling effect that is observed for individuals consuming a diet containing more than ϳ700 mg/day (6, 40) . We showed that the CaR activated NFAT to increase PGE 2 synthesis via a mechanism involving TNF production and COX-2 expression in the mTAL and contributing to inhibition of ouabain-sensitive O 2 consumption, an in vitro correlate of natriuresis in the mTAL. Interestingly, dietary Ca 2ϩ supplementation prevented NaCl-dependent increases in BP by prompting an alteration in renal function; namely, the rapid adjustment of extracellular fluid volume via diuresis and natriuresis (6, 46) . These studies indicate that high Ca 2ϩ intake facilitates salt and water excretion consistent with the inhibitory effects on Na ϩ transport in response to the CaR/TNF/COX-2 pathway that operates in the mTAL. Also, consistent with this role of Ca 2ϩ intake on salt excretion are the experiments in which a dominant negative CaR (R796W) overexpressed in mTAL cells prevented the inhibitory effects of CaR activation on ouabain-sensitive O 2 consumption. These in vitro experiments support those studies indicating that persons with inactivating CaR mutations exhibit an impaired ability to excrete Ca 2ϩ in response to hypercalcemia, while individuals with activating CaR mutations had excessively high urinary Ca 2ϩ excretion, thus supporting a significant role for the CaR in affecting salt and water excretion (3, 6, 10, 27) . Furthermore, hypercalcemia in rats produced polyuria and natriuresis associated with decreased expression of the NKCC2 and ROMK in the inner stripe of the outer medulla (36, 61) . Interestingly, vasopressin increased NKCC2 expression, as well as NaCl reabsorption (33) . Vasopressin regulates the countercurrent multiplication system and is modulated by increases in cAMP and PKC activity. Decreased responsiveness of the kidney to vasopressin appears to be an important cause of polyuria in hypercalcemia associated with changes in adenylate cyclase and PKC activities (4, 11, 25, 34, 45) . Thus, CaR-mediated G q -and G i -coupled signaling that inhibits transporter function in a PGE 2 -dependent manner may counteract the effects of vasopressin in the mTAL, a mechanism that likely acts in concert with the CaR-mediated antagonism of AVP-dependent water permeability in the collecting duct (51) .
We showed that the CaR signals in a G q -and G i -dependent manner that is CaN/NFAT mediated to increase PGE 2 synthesis via a TNF-dependent manner (2) . We conclude that an autocrine mechanism involving detection of extracellular Ca 2ϩ in the mTAL regulates salt and water balance initiated by CaR-mediated COX-2-derived PGE 2 production correlated with greatly diminished ouabain-sensitive O 2 consumption.
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